Latest Array comparative genomic hybridization Stories
ALISO VIEJO, Calif., Sept. 1 /PRNewswire/ -- Ambry Genetics announced today that they have completed certification to become an Agilent Certified Service Provider on the Agilent microarray platform.
ALISO VIEJO, Calif., June 3 /PRNewswire/ -- Ambry Genetics is pleased to announce the launch of whole-genome Chromosomal Microarray Analysis (CMA), offering the Ambry CMA: 105K Oligo Array, which is designed to identify chromosomal abnormalities associated with over 270 genetic disorders.
ALISO VIEJO, Calif., May 5 /PRNewswire/ -- Ambry Genetics Corp. announces the implementation of Comparative Genomic Hybridization (CGH) using oligonucleotide arrays through a partnership with Baylor College of Medicine.
A fertility clinic in Nottingham, England has announced the world's first pregnancy using a new technique that screens eggs for abnormalities that cause in vitro fertilization (IVF) to fail.
By Muradyan, Artur Boldt, Vivien; Steininger, Anne; Stabentheiner, Stephanie; Tebel, Katrin; Kreutzberger, Jurgen; Muller, Ines; Madle, Hannelore; Popper, Helmut H; Ullmann, Reinhard The accumulation of chromosomal aberrations is a characteristic feature of tumor development.
Researchers from France investigating DNA copy number changes associated with genetic disorders have reported the development and validation of a Roche NimbleGen CGH multiplex, microarray-based research method for detecting genomic deletions and duplications at high-resolution.
Chromosomal rearrangements leading to genomic disorders are often mediated by low-copy repeat regions of the genome (e.g. segmental duplications). Roche NimbleGen CGH arrays offer expanded probe coverage in these regions.
- The word or words serving to define another word or expression, as in a dictionary entry.